Tilus, Riezza Ann H.

HRN: 26-85-06  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2026
CO-AMOXICLAV 625MG (TAB)
02/03/2026
02/10/2026
PO
625 MG/TAB
TID
CAP LR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines